Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Exp Neurol ; 285(Pt A): 96-107, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27567739

ABSTRACT

In mutant superoxide dismutase 1 (SOD1) mouse models of familial amyotrophic lateral sclerosis (fALS) some of the earliest signs of morphological and functional damage occur in the motor nerve terminals that innervate fast limb muscles. This study tested whether localized peripheral application of a protective drug could effectively preserve neuromuscular junctions in late-stage disease. Methylene blue (MB), which has mitochondria-protective properties, was infused via an osmotic pump into the anterior muscle compartment of one hind limb of late pre- symptomatic SOD1-G93A mice for ≥3weeks. When mice reached end-stage disease, peak twitch and tetanic contractions evoked by stimulation of the muscle nerve were measured in two anterior compartment muscles (tibialis anterior [TA] and extensor digitorum longus [EDL], both predominantly fast muscles). With 400µM MB in the infusion reservoir, muscles on the MB-infused side exhibited on average a ~100% increase in nerve-evoked contractile force compared to muscles on the contralateral non-infused side (p<0.01 for both twitch and tetanus in EDL and TA). Pairwise comparisons of endplate innervation also revealed a beneficial effect of MB infusion, with an average of 65% of endplates innervated in infused EDL, compared to only 35% on the non-infused side (p<0.01). Results suggested that MB's protective effects required an extracellular [MB] of ~1µM, were initiated peripherally (no evidence of retrograde transport into the spinal cord), and involved MB's reduced form. Thus peripherally-initiated actions of MB can help preserve neuromuscular structure and function in SOD1-G93A mice, even at late stages of disease.


Subject(s)
Amyotrophic Lateral Sclerosis/complications , Enzyme Inhibitors/administration & dosage , Methylene Blue/administration & dosage , Neuromuscular Junction Diseases/drug therapy , Neuromuscular Junction Diseases/etiology , Superoxide Dismutase/genetics , Amyotrophic Lateral Sclerosis/drug therapy , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Animals , Bungarotoxins/pharmacokinetics , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Delivery Systems , Enzyme Inhibitors/therapeutic use , Fluorescent Antibody Technique , Humans , Methylene Blue/therapeutic use , Mice , Mice, Transgenic , Motor Endplate/drug effects , Motor Endplate/physiology , Muscle Contraction/drug effects
2.
Exp Neurol ; 234(1): 95-104, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22206924

ABSTRACT

Motor nerve terminals are especially sensitive to an ischemia/reperfusion stress. We applied an in vitro model of this stress, oxygen/glucose deprivation (OGD), to mouse neuromuscular preparations to investigate how Ca(2+) contributes to stress-induced motor terminal damage. Measurements using an ionophoretically-injected fluorescent [Ca(2+)] indicator demonstrated an increase in intra-terminal [Ca(2+)] following OGD onset. When OGD was terminated within 20-30min of the increase in resting [Ca(2+)], these changes were sometimes reversible; in other cases [Ca(2+)] remained high and the terminal degenerated. Endplate innervation was assessed morphometrically following 22min OGD and 120min reoxygenation (32.5°C). Stress-induced motor terminal degeneration was Ca(2+)-dependent. Median post-stress endplate occupancy was only 26% when the bath contained the normal 1.8mM Ca(2+), but increased to 81% when Ca(2+) was absent. Removal of Ca(2+) only during OGD was more protective than removal of Ca(2+) only during reoxygenation. Post-stress endplate occupancy was partially preserved by pharmacological inhibition of various routes of Ca(2+) entry into motor terminals, including voltage-dependent Ca(2+) channels (ω-agatoxin-IVA, nimodipine) and the plasma membrane Na(+)/Ca(2+) exchanger (KB-R7943). Inhibition of a Ca(2+)-dependent protease with calpain inhibitor VI was also protective. These results suggest that most of the OGD-induced motor terminal damage is Ca(2+)-dependent, and that inhibition of Ca(2+) entry or Ca(2+)-dependent proteolysis can reduce this damage. There was no significant difference between the response of wild-type and presymptomatic superoxide dismutase 1 G93A mutant terminals to OGD, or in their response to the protective effect of the tested drugs.


Subject(s)
Calcium/metabolism , Glucose/deficiency , Hypoxia/pathology , Motor Endplate/pathology , Motor Neuron Disease/pathology , Neuromuscular Junction/physiopathology , Animals , Bacterial Proteins/genetics , Bungarotoxins/metabolism , Disease Models, Animal , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacokinetics , Enzyme Inhibitors/pharmacokinetics , Humans , In Vitro Techniques , Luminescent Proteins/genetics , Membrane Potential, Mitochondrial/physiology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Motor Neuron Disease/genetics , Motor Neurons/metabolism , Motor Neurons/pathology , Protein Binding/drug effects , Superoxide Dismutase/genetics , Thiourea/analogs & derivatives , Thiourea/pharmacokinetics , Time Factors
3.
J Neurochem ; 105(3): 807-19, 2008 May.
Article in English | MEDLINE | ID: mdl-18205748

ABSTRACT

The Alamar blue (resazurin) assay of cell viability monitors the irreversible reduction of non-fluorescent resazurin to fluorescent resorufin. This study focused on the reversible reduction of C12-resorufin to non-fluorescent C12-dihydroresorufin in motor nerve terminals innervating lizard intercostal muscles. Resting C12-resorufin fluorescence decreased when the activity of the mitochondrial electron transport chain (ETC) was accelerated with carbonyl cyanide m-chloro phenyl hydrazone, and increased when ETC activity was inhibited with cyanide. Trains of action potentials (50 Hz for 20-50 s), which reversibly decreased NADH fluorescence and partially depolarized the mitochondrial membrane potential, produced a reversible decrease in C12-resorufin fluorescence which had a similar time course. The stimulation-induced decrease in C12-resorufin fluorescence was blocked by inhibitors of ETC complexes I, III, and IV and by carbonyl cyanide m-chloro phenyl hydrazone, but not by inhibiting mitochondrial ATP synthesis with oligomycin. Mitochondrial depolarization and the decreases in C12-resorufin and NADH fluorescence depended on Ca2+ influx into the terminal, but not on vesicular transmitter release. These results suggest that the reversible reduction of C12-resorufin in stimulated motor nerve terminals is linked, directly or indirectly, to the reversible oxidation of NADH and to Ca(2+) influx into mitochondria, and provides an assay for rapid changes in motor terminal metabolism.


Subject(s)
Energy Metabolism/physiology , Mitochondria/metabolism , Motor Neurons/metabolism , Neuromuscular Junction/metabolism , Oxazines/chemistry , Presynaptic Terminals/metabolism , Action Potentials/physiology , Animals , Biological Assay/methods , Calcium Signaling/physiology , Carbon Isotopes/chemistry , Electron Transport Chain Complex Proteins/drug effects , Electron Transport Chain Complex Proteins/metabolism , Energy Metabolism/drug effects , Fluorescence , Indicators and Reagents , Lizards , Microscopy, Fluorescence , Mitochondria/drug effects , NAD/metabolism , Neurochemistry/methods , Oxidation-Reduction , Uncoupling Agents/pharmacology
4.
J Neurophysiol ; 90(1): 491-502, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12672777

ABSTRACT

We investigated how inhibition of mitochondrial Ca2+ uptake affects stimulation-induced increases in cytosolic [Ca2+] and phasic and asynchronous transmitter release in lizard motor terminals in 2 and 0.5 mM bath [Ca2+]. Lowering bath [Ca2+] reduced the rate of rise, but not the final amplitude, of the increase in mitochondrial [Ca2+] during 50-Hz stimulation. The amplitude of the stimulation-induced increase in cytosolic [Ca2+] was reduced in low-bath [Ca2+] and increased when mitochondrial Ca2+ uptake was inhibited by depolarizing mitochondria. In 2 mM Ca2+, end-plate potentials (epps) depressed by 53% after 10 s of 50-Hz stimulation, and this depression increased to 80% after mitochondrial depolarization. In contrast, in 0.5 mM Ca2+ the same stimulation pattern increased epps by approximately 3.4-fold, and this increase was even greater (transiently) after mitochondrial depolarization. In both 2 and 0.5 mM [Ca2+], mitochondrial depolarization increased asynchronous release during the 50-Hz train and increased the total vesicular release (phasic and asynchronous) measured by destaining of the styryl dye FM2-10. These results suggest that by limiting the stimulation-induced increase in cytosolic [Ca2+], mitochondrial Ca2+ uptake maintains a high ratio of phasic to asynchronous release, thus helping to sustain neuromuscular transmission during repetitive stimulation. Interestingly, the quantal content of the epp reached during 50-Hz stimulation stabilized at a similar level ( approximately 20 quanta) in both 2 and 0.5 mM Ca2+. A similar convergence was measured in oligomycin, which inhibits mitochondrial ATP synthesis without depolarizing mitochondria, but quantal contents fell to <20 when mitochondria were depolarized in 2 mM Ca2+.


Subject(s)
Calcium Signaling/drug effects , Calcium/metabolism , Mitochondria/metabolism , Motor Neurons/metabolism , Presynaptic Terminals/metabolism , Synaptic Transmission , Animals , Cytosol/metabolism , Electric Stimulation , Electrophysiology , Enzyme Inhibitors/pharmacology , Lizards , Mitochondria/drug effects , Motor Neurons/drug effects , Motor Neurons/physiology , Muscle Contraction , Muscle, Skeletal/metabolism , Oligomycins/pharmacology , Presynaptic Terminals/drug effects , Presynaptic Terminals/physiology , Synaptic Transmission/drug effects , Synaptic Vesicles/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL